The Conundrum of Opioid Tapering in Long-Term Opioid Therapy for Chronic Pain: A Commentary
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Background: In response to the opioid epidemic and new guidelines, many patients on high-dose long term opioid therapy (LTOT) for chronic pain are getting tapered off opioids. As a result, a unique clinical challenge is emerging: while many on LTOT have poor pain control, functional decline, psychiatric instability, aberrancies and misuse, these issues may often worsen with opioid tapering. Currently, a clear explanation and practical guidance on how to manage this perplexing clinical scenario is lacking. Methods: We offer a commentary with our perspective on possible mechanisms involved in this clinical phenomena and offer practical management guidance, supported by available evidence. Results: It is not well recognized that allostatic opponent process involved in development of opioid dependence can cause worsening pain, functional status, sleep and psychiatric symptoms over time, and significant fluctuation of pain and other affective symptoms due to their bidirectional dynamic interaction with opioid dependence (‘affective dynamism’). These elements of complex persistent dependence (CPD), the grey area between simple dependence and addiction, can lead to escalating and labile opioid need, often generating aberrant behaviors. Opioid tapering, a seemingly logical intervention in this situation, may lead to worsening of pain, function and psychiatric symptoms due to development of protracted abstinence syndrome. We offer practicing clinicians management principles and practical guidance focused on management of CPD in addition to chronic pain in these difficult clinical scenarios. Conclusion: Awareness of the science of the neuroplasticity effects of repeated use of opioids is necessary to better manage these patients with complex challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“At the cellular level tolerance occurs because of the drive to homeostatic balance, 2 involving de-sensitisation and down-regulation of MORs, as well as modifications to the mu-signalosome, neuronal proteome, transcriptome and neuronal morphology, 20 with consequent downstream effects on mesolimbic dopaminergic neurons.19,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Withdrawal symptoms occur when opioids are reduced or stopped because the raised homeostatic set-point of the mu-opioid system registers reduced doses as ‘under activation’.2,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Opioids produce their analgesic and dependency-forming effects through agonism of opioid receptors, and, most importantly, the MOR, with downstream effect on GABAergic and dopaminergic neurotransmission.2,19,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Tolerance develops with repeated use whereby, as a result of changes at the metabolic or cellular level, the same dose produces less effect, or higher doses are required to achieve the same effect.2,20”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“these periods of time likely reflect the time period required for adaptations of the opioid system to resolve.2,20,46,47”
From Tapering and withdrawing opioids: guidance informed by fundamental principles to minimise withdrawal symptoms (2025) · cites this paper as [2]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · JAMA · doi:10.1001/jama.2016.1464 · Cited by 5,161
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,219
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
Dowell, D., Haegerich, T. M., & Chou, R. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6501e1 · Cited by 2,697
Alcoholism: Clinical and Experimental Research
(2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/(issn)1530-0277 · Cited by 1,831
Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies
Volkow, N. D., & McLellan, A. T. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1507771 · Cited by 1,305
Addiction and the brain: The neurobiology of compulsion and its persistence
Hyman, S. E., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35094560 · Cited by 1,302
The opponent-process theory of acquired motivation: the costs of pleasure and the benefits of pain
Solomon, R. L. (1980) · American Psychologist · doi:10.1037/0003-066x.35.8.691 · Cited by 1,194
Neurobiological mechanisms for opponent motivational processes in addiction
Koob, G. F., & Le Moal, M. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0094 · Cited by 702
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
Reward and motivation in pain and pain relief
Navratilova, E., & Porreca, F. (2014) · Nature Neuroscience · doi:10.1038/nn.3811 · Cited by 477
Opponent appetitive-aversive neural processes underlie predictive learning of pain relief
Seymour, B., O'Doherty, J. P., Koltzenburg, M., Wiech, K., Frackowiak, R., Friston, K., & Dolan, R. (2005) · Nature Neuroscience · doi:10.1038/nn1527 · Cited by 439
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
REVIEW: Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?
Heilig, M., Egli, M., Crabbe, J. C., & Becker, H. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00194.x · Cited by 435
Efficacy of Opioids for Chronic Pain: A Review of the Evidence
Ballantyne, J. C., & Shin, N. S. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816b2f26 · Cited by 360
Self-citationBuprenorphine: Considerations for Pain Management
Johnson, R. E., Fudala, P. J., & Payne, R. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2004.07.005 · Cited by 290
Drug addiction: Pathways to the disease and pathophysiological perspectives
Le Moal, M., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.10.006 · Cited by 283
Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence
Koob, G. F., Stinus, L., Moal, M. L., & Bloom, F. E. (1989) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(89)80022-3 · Cited by 268
Morphine tolerance as habituation.
Baker, T. B., & Tiffany, S. T. (1985) · Psychological Review · doi:10.1037//0033-295x.92.1.78 · Cited by 224
Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain
Shurman, J., Koob, G. F., & Gutstein, H. B. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00881.x · Cited by 215
Tapering Long-term Opioid Therapy in Chronic Noncancer Pain
Berna, C., Kulich, R. J., & Rathmell, J. P. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.04.003 · Cited by 214
Yi, P., & Pryzbylkowski, P. (2015) · Pain Medicine · doi:10.1111/pme.12914 · Cited by 190
The importance of context: When relative relief renders pain pleasant
Leknes, S., Berna, C., Lee, M. C., Snyder, G. D., Biele, G., & Tracey, I. (2013) · Pain · doi:10.1016/j.pain.2012.11.018 · Cited by 189
Understanding how opioids contribute to reward and analgesia
Fields, H. L. (2007) · Regional Anesthesia and Pain Medicine · doi:10.1097/00115550-200705000-00012 · Cited by 166
Should protracted withdrawal from drugs be included in DSM-IV?
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.5.695 · Cited by 158
Opioid use behaviors, mental health and pain—Development of a typology of chronic pain patients
Banta-Green, C. J., Merrill, J. O., Doyle, S. R., Boudreau, D. M., & Calsyn, D. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.021 · Cited by 137
Research on Tolerance: What Can We Learn From History?
Kalant, H. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03618.x · Cited by 130
Pleasure into pain: The consequences of long-term opioid use
White, J. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.007 · Cited by 127
Howe, C. Q., & Sullivan, M. D. (2013) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.10.003 · Cited by 127
Why Doctors Prescribe Opioids to Known Opioid Abusers
Lembke, A. (2012) · New England Journal of Medicine · doi:10.1056/nejmp1208498 · Cited by 122
Pain relief as an opponent process: a psychophysical investigation
Leknes, S., Brooks, J. C. W., Wiech, K., & Tracey, I. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06380.x · Cited by 121
Psychological Methods of Pain Control: Basic Science and Clinical Perspectives
(2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e669 · Cited by 99
Positive emotions and brain reward circuits in chronic pain
Navratilova, E., Morimura, K., Xie, J. Y., Atcherley, C. W., Ossipov, M. H., & Porreca, F. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.23968 · Cited by 99
Article Commentary: Turning the Tide or Riptide? The Changing Opioid Epidemic
Kertesz, S. G. (2017) · Substance Abuse · doi:10.1080/08897077.2016.1261070 · Cited by 99
Neumann, A. M., Blondell, R. D., Jaanimägi, U., Giambrone, A. K., Homish, G. G., Lozano, J. R., Kowalik, U., & Azadfard, M. (2013) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.759872 · Cited by 90
Opioid Dependence vs Addiction: A Distinction Without a Difference?
Ballantyne, J. C., Sullivan, M. D., & Kolodny, A. (2012) · Archives of Internal Medicine · doi:10.1001/archinternmed.2012.3212 · Cited by 89
Self-citationTargeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations
Arout, C. A., Edens, E., Petrakis, I. L., & Sofuoglu, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0255-x · Cited by 80
The Nature of Pain Offset Relief in Nonsuicidal Self-Injury: A Laboratory Study
Franklin, J. C., Puzia, M. E., Lee, K. M., Lee, G. E., Hanna, E. K., Spring, V. L., & Prinstein, M. J. (2013) · Clinical Psychological Science · doi:10.1177/2167702612474440 · Cited by 71
Motivational Processes Underlying Substance Abuse Disorder
Meyer, P., King, C. P., & Ferrario, C. R. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_391 · Cited by 63
Blondell, R. D., Ashrafioun, L., Dambra, C. M., Foschio, E. M., Zielinski, A. L., & Salcedo, D. M. (2010) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e3181ba895d · Cited by 59
Lee, M. C., Wanigasekera, V., & Tracey, I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.035 · Cited by 56
Classical conditioning and pain: Conditioned analgesia and hyperalgesia
Míguez, G., Laborda, M. A., & Miller, R. R. (2013) · Acta Psychologica · doi:10.1016/j.actpsy.2013.10.009 · Cited by 56
Drug tolerance: a known unknown in translational neuroscience
Bespalov, A., Müller, R., Relo, A.-L., & Hudzik, T. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.008 · Cited by 50
Assessing the prevalence of opioid misuse, abuse, and addiction in chronic pain
Ballantyne, J. C. (2015) · Pain · doi:10.1097/j.pain.0000000000000105 · Cited by 49
Self-citationFoster, B., Twycross, R., Mihalyo, M., & Wilcock, A. (2013) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2013.03.001 · Cited by 49
Methadone treatment of chronic non‐malignant pain and opioid dependence — A long‐term follow‐up
Rhodin, A., Grönbladh, L., Nilsson, L. ‐., & Gordh, T. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.05.003 · Cited by 48
Buprenorphine—Clinically useful but often misunderstood
Butler, S. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.05.004 · Cited by 47
Opioid-Induced Hyperalgesia: Is It Clinically Relevant for the Treatment of Pain Patients?
Raffa, R. B., & Pergolizzi, J. V. (2011) · Pain Management Nursing · doi:10.1016/j.pmn.2011.04.002 · Cited by 45
Opioid-Induced Hyperalgesia (OIH): A Real Clinical Problem or Just an Experimental Phenomenon?
Eisenberg, E., Suzan, E., & Pud, D. (2014) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2014.07.005 · Cited by 43
A Chronic Opioid Therapy Dose Reduction Policy in Primary Care
Weimer, M. B., Hartung, D. M., Ahmed, S., & Nicolaidis, C. (2016) · Substance Abuse · doi:10.1080/08897077.2015.1129526 · Cited by 42
Stopping or Decreasing Opioid Therapy in Patients on Chronic Opioid Therapy
Pergolizzi, J. V., Varrassi, G., Paladini, A., & LeQuang, J. A. (2019) · Pain and Therapy · doi:10.1007/s40122-019-00135-6 · Cited by 42
When Opioids Fail in Chronic Pain Management: The Role for Buprenorphine and Hospitalization
Berland, D. W., Malinoff, H. L., Weiner, M. A., & Przybylski, R. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31827ab599 · Cited by 29
Chang, H., Krawczyk, N., Schneider, K. E., Ferris, L. M., Eisenberg, M. D., Richards, T. M., Lyons, B. C., Jackson, K., Weiner, J. P., & Saloner, B. K. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.04.016 · Cited by 26
Heit, H. A., Covington, E. C., & Good, P. M. (2004) · Pain Medicine · doi:10.1111/j.1526-4637.2004.04044.x · Cited by 26
White, R., Hayes, C., Boyes, A., Chiu, S. K., & Paul, C. L. (2019) · Journal of Pain Research · doi:10.2147/jpr.s168785 · Cited by 25
Responding to America’s Iatrogenic Epidemic of Prescription Opioid Addiction and Overdose
Korff, M. R. V., & Franklin, G. M. (2016) · Medical Care · doi:10.1097/mlr.0000000000000537 · Cited by 23
Weeks, W. B. (2016) · JAMA · doi:10.1001/jama.2016.10251 · Cited by 18
Pain Signal as Threat and Reward
Zubieta, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.002 · Cited by 8
Research works printed but not linked: 6
- 10.1037/0033-295x.92.1.78 · doi:10.1037/0033-295x.92.1.78 · Paper page
- 10.15585/mmwr.rr6501e1 · DOI · Paper page
- Ballantyne JC, , Stannard C. New addiction criteria: diagnostic challenges persist in treating pain with opioids. Pain. 2013;1.
- SAMHSA. Protracted withdrawal. Substance abuse treatment advisory. 2010;9(1):1–8.
- Center for Substance Abuse T. SAMHSA/CSAT Treatment Improvement Protocols. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2004.
- VA/DoD Clinical Practive Guideleine Management of Opioid Therapy for Chronic pain. The Management of Opioid Therapy for Chronic Pain Working Group;2010.
Cited by
CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022
Dowell, D., Ragan, K. R., Jones, C. M., Baldwin, G. T., & Chou, R. (2022) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7103a1 · Cited by 1,886
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Agnoli, A., Xing, G., Tancredi, D. J., Magnan, E., Jerant, A., & Fenton, J. J. (2021) · JAMA · doi:10.1001/jama.2021.11013 · Cited by 273
Kroenke, K., Alford, D. P., Argoff, C., Canlas, B., Covington, E., Frank, J. W., Haake, K. J., Hanling, S., Hooten, W. M., Kertesz, S. G., et al. (2019) · Pain Medicine · doi:10.1093/pm/pny307 · Cited by 214
Babu, K. M., Brent, J. A., & Juurlink, D. N. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807054 · Cited by 133
Metadata
- Authors
- Manhapra, A., Arias, A. J., & Ballantyne, J. C.
- Affiliations
- Yale University (US)
- University of Washington (US)
- Corresponding author
- Manhapra, Ajay
- Venue
- Substance Abuse
- Publisher
- SAGE Publications
- Published
- 2018-04
- Volume
- 39
- Issue
- 2
- Pages
- 152-161
- ISSN
- 0889-7077 (ISSN-L)
- 1547-0164
- PMC
- PMC6129223
- OpenAlex
- W2755855796
- Cited by
- 98
- References
- 57
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 15 · 2020: 21 · 2019: 9 · 2018: 9
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Substance Abuse (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R25DA033211)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- opioid tapering, long-term opioid therapy, chronic pain, opioid use disorder, opponent process theory, withdrawal syndrome, pain fluctuation, psychiatric symptoms, functional decline, opioid misuse, opioid epidemic, neuroplasticity
- MeSH terms
- Analgesics, Opioid, Drug Administration Schedule, Humans, Opioid-Related Disorders, Withholding Treatment, Chronic Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.